Mag 2 2.25 g - magnesium deficiency - 20 effervescent tablets

Product Description

Mag 2 2.25g Effervescent Tablets indicated in magnesium deficiency states.

Active ingredients

One effervescent tablet contains: active ingredient: magnesium pidolate 2.250 g (corresponding to 184 mg of Mg++ ion); excipients: sorbitol (see also section 4.4). For a full list of excipients, see section 6.1.

Excipients

Anhydrous citric acid, sodium bicarbonate, sorbitol, anhydrous sodium carbonate, lemon flavouring, orange flavouring, acesulfame potassium, anhydrous colloidal silica.

Contraindications

Hypersensitivity to the active substance or to any of the excipients. Severe renal insufficiency (creatinine clearance less than 30 mL/min). Not to be administered to patients undergoing digitalis therapy.

Dosage

For adults only: 2 effervescent tablets per day. In children, the dosage may be established by a doctor in advance. Caution: use only for short periods of treatment.

Warnings and precautions

In patients with renal insufficiency, it is necessary to reduce the dosage and monitor renal function and magnesium levels. The possibility of cardiovascular and respiratory depression during treatment should be considered. Patients with rare hereditary problems of fructose intolerance should not take this medicine.

Interactions

Oral administration of magnesium may cause an increased risk of cardiovascular disease. Magnesium-containing products may cause reduced absorption of tetracyclines, therefore it is recommended not to administer MAG2 simultaneously with tetracycline-based drugs, but to maintain at least 3-4 hours between the two administrations. Quinolones should be administered at least 2 hours before or 6 hours after the administration of magnesium-based products to avoid interference with their absorption. In the case of concomitant administration of magnesium-based products and cholecalciferol (vitamin D3), monitoring of calcium levels is recommended to avoid the possible onset of hypercalcemia. The concomitant use of preparations containing calcium or phosphate salts is not recommended as these products prevent the absorption of magnesium. The simultaneous intake of magnesium-based products with drugs that depress the central nervous system can potentiate the effects of magnesium on the CNS and must be carefully evaluated.

Format

20 effervescent tablets